Scarica l'app Stockscreener
25.58
0.16%
-0.04
Dopo l'orario di chiusura:
25.58
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies Officer Susan Bobulsky Files to Sell 6,444 Shares Under 10b5-1 Plan - Kalkine Media
Adaptive Biotechnologies COO Julie Rubinstein sells $1m in stock - Investing.com
Form 4 Adaptive Biotechnologies Corp For: 5 October By Investing.com - Investing.com Nigeria
An officer exercises options and sells Adaptive Biotechnologies (ADPT) shares under a preset plan. - Stock Titan
A COO exercises $12.14 options and sells 35,643 Adaptive Biotechnologies (ADPT) shares. - Stock Titan
Adaptive Biotechnologies Officer Julie Rubinstein Files Form 144 to Sell 379,777 Shares - Kalkine Media
Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). - Stock Titan
Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com - Investing.com Canada
Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (ADPT) HR chief sells over 100,000 shares under preset plan - Stock Titan
Adaptive biotechnologies chief commercial officer sells $32,265 in shares. - Investing.com
Adaptive Biotechnologies (NASDAQ: ADPT) CCO sells shares under pre-set trading plan - Stock Titan
Adaptive Biotechnologies (ADPT) officer to sell 142K shares - Stock Titan
Officer at Adaptive Biotechnologies (NASDAQ: ADPT) plans sale of 1,195 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) director reports stock gift, still holds 66,100 shares - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Morgan Stanley’s healthcare conference sets a biotech chat for Sept. 15 - Stock Titan
Adaptive Biotechnologies Corp (ADPT) Peer Comparison – Compare with Others - Value Research
Director Katey Owen Sells 9,615 Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com - Investing.com India
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com - Investing.com Canada
Adaptive Biotechnologies director Owen sells $249,990 in stock. - Investing.com
Adaptive Biotechnologies Corp (ADPT) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Adaptive Biotechnologies (NASDAQ: ADPT) director sells at $26, keeps 78,639 - Stock Titan
Adaptive Biotechnologies stock hits 52-week high at $26.63 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies stock hits 52-week high at $26.63 - Investing.com
Adaptive Biotechnologies stock hits 52-week high at $26.63 - Investing.com India
Adaptive Biotechnologies stock hits 52-week high at $26.63 By Investing.com - Investing.com UK
Adaptive Biotech (NASDAQ: ADPT) director lines up $249,990 stock sale - Stock Titan
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl
Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - Yahoo Finance
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com South Africa
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com India
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com UK
Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock - MarketBeat
Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com
Adaptive Biotechnologies Director Robert Hershberg Executes Stock Option and Sells Shares - Kalkine Media
Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) director exercises option at $6.32 strike - Stock Titan
Adaptive Biotechnologies director Neupert sells $3.1m in stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com India
Adaptive Biotechnologies director Neupert sells $3.1m in stock - Investing.com
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com Canada
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com UK
Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares - Investing.com
Adaptive Biotechnologies director Neupert sells $3.1m in stock - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins Sells 278,676 Shares - MarketBeat
2.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):